Low ectonucleotidase activity and increased neutrophil-platelet aggregates in patients with antiphospholipid syndrome

2.

Tambralli

A

,

Gockman

K

,

Knight

JS

.

NETs in APS: current knowledge and future perspectives

.

Curr Rheumatol Rep

.

2020

;

22

(

10

):

67

.

3.

Knight

JS

,

Branch

DW

,

Ortel

TL

.

Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management

.

BMJ

.

2023

;

380

:

e069717

.

4.

Wang

X

,

Chen

D

.

Purinergic regulation of neutrophil function

.

Front Immunol

.

2018

;

9

:

399

.

5.

Gachet

C

,

Hechler

B

.

Platelet purinergic receptors in thrombosis and inflammation

.

Hämostaseologie

.

2020

;

40

(

2

):

145

-

152

.

6.

Darbousset

R

,

Delierneux

C

,

Mezouar

S

, et al.

P2X1 expressed on polymorphonuclear neutrophils and platelets is required for thrombosis in mice

.

Blood

.

2014

;

124

(

16

):

2575

-

2585

.

7.

Ming

Y

,

Xin

G

,

Ji

B

, et al.

Entecavir as a P2X7R antagonist ameliorates platelet activation and thrombus formation

.

J Pharmacol Sci

.

2020

;

144

(

1

):

43

-

51

.

8.

Knight

JS

,

Mazza

LF

,

Yalavarthi

S

, et al.

Ectonucleotidase-mediated suppression of lupus autoimmunity and vascular dysfunction

.

Front Immunol

.

2018

;

9

:

1322

.

9.

Ali

RA

,

Gandhi

AA

,

Meng

H

, et al.

Adenosine receptor agonism protects against NETosis and thrombosis in antiphospholipid syndrome

.

Nat Commun

.

2019

;

10

(

1

):

1916

.

10.

Hechler

B

,

Gachet

C

.

Purinergic receptors in thrombosis and inflammation

.

Arterioscler Thromb Vasc Biol

.

2015

;

35

(

11

):

2307

-

2315

.

11.

Chaurasia

SN

,

Kushwaha

G

,

Pandey

A

,

Dash

D

.

Human platelets express functional ectonucleotidases that restrict platelet activation signaling

.

Biochem Biophys Res Commun

.

2020

;

527

(

1

):

104

-

109

.

12.

Corriden

R

,

Chen

Y

,

Inoue

Y

, et al.

Ecto-nucleoside triphosphate diphosphohydrolase 1 (E-NTPDase1/CD39) regulates neutrophil chemotaxis by hydrolyzing released ATP to adenosine

.

J Biol Chem

.

2008

;

283

(

42

):

28480

-

28486

.

13.

Morello

S

,

Caiazzo

E

,

Turiello

R

,

Cicala

C

.

Thrombo-inflammation: a focus on NTPDase1/CD39

.

Cells

.

2021

;

10

(

9

):

2223

.

14.

Covarrubias

R

,

Chepurko

E

,

Reynolds

A

, et al.

Role of the CD39/CD73 purinergic pathway in modulating arterial thrombosis in mice

.

Arterioscler Thromb Vasc Biol

.

2016

;

36

(

9

):

1809

-

1820

.

15.

Yalavarthi

S

,

Gould

TJ

,

Rao

AN

, et al.

Release of neutrophil extracellular traps by neutrophils stimulated with antiphospholipid antibodies: a newly identified mechanism of thrombosis in the antiphospholipid syndrome

.

Arthritis Rheumatol

.

2015

;

67

(

11

):

2990

-

3003

.

16.

Urbanus

RT

,

Pennings

MT

,

Derksen

RH

,

de Groot

PG

.

Platelet activation by dimeric beta2-glycoprotein I requires signaling via both glycoprotein Ibalpha and apolipoprotein E receptor 2'

.

J Thromb Haemost

.

2008

;

6

(

8

):

1405

-

1412

.